CCC

In recent years, the healthcare landscape has witnessed a profound shift as plant-based medicines, including cannabis, have emerged as contenders to traditional pharmaceuticals. Plant medicine refers to the use of natural substances derived from plants and herbs for therapeutic and medicinal...

Tilray Brands (NASDAQ: TLRY) chairman and CEO Irwin D. Simon says his company is set to capitalize on possible cannabis legalization in the U.S. and anticipates creating beer infused with cannabis if/when it becomes legal. Simon has long been optimistic about legalization...

Senate Banking Committee Chairman Sherrod Brown (D-OH) says he'll announce the scheduling of a marijuana banking bill vote in his panel soon, aiming to hold the markup session before October 6. However, he acknowledges that there are unresolved issues among committee members that need to be...

Leafly Holdings (NASDAQ: LFLY) announced that the 1-for-20 reverse stock split of its common stock, par value $0.0001 became effective on September 12, 2023, at 12:01 a.m. ET. Leafly’s Common Stock will continue trading on the Nasdaq under its existing symbol “LFLY...

In an exclusive interview with Benzinga, Carlos Pinto, chief commercial officer (CCO) of Leafly Holdings Inc. (NASDAQ: LFLY) discussed the strategic shift the cannabis marketplace and education platform has undergone. He also shared his perspective on the Department of Health...

Retail weed sales in Massachusetts hit the $5 billion mark, according to a press release from the state’s Cannabis Control Commission (CCC). In January, adult-use sales reached $4 billion and a mere eight months later surged to $5 billion. With more East Coast states...

As the cannabis industry continues to evolve, revealing data analysis by Zuanic & Associates sheds light on a captivating paradox: while flower sales have shown signs of growth, their dominance has waned, unveiling a changing landscape. Over nearly three years, flower sales have bloomed by 62...

Ever wondered how the fusion of cultural values and cannabis business models could amplify your financial gains? Curious about how cannabis culture's evolution could impact your investment portfolio? Chicago is gearing up to host the Benzinga Cannabis Capital Conference on September 27 and 28,...

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

In his weekly Dear Colleague letter, Senate Majority Leader Chuck Schumer (D-NY) renewed his call to pass a cannabis banking bill before the legislative period runs out. "In the remaining months of this year, we also have an opportunity to advance legislation on a number of...

What intricate interplays of manufacturing strategies and market dynamics hold the key to enhanced return on investment (ROI) within the cannabis supply chain? This strategic approach not only caters to diverse consumer preferences but also holds the potential to amplify profitability and open...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...

As the marijuana industry continues to evolve and gain momentum across the United States, two governors stand out for their significant contributions to shaping cannabis policy and its economic impact. Governor JB Pritzker of Illinois and Governor Albert Bryan Jr. of the U.S. Virgin Islands...

New York Senator Chuck Schumer (D) responded to Wednesday's news that the Dept. of  Health and Human Services wrote to DEA administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act.  Cannabis'...